Public Sector Pension Investment Board (PSP Investments)’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.27M | Sell |
199,351
-5,807
| -3% | -$279K | 0.02% | 692 |
|
|
2026
Q1 | $10.6M | Buy |
205,158
+6,752
| +3% | +$344K | 0.03% | 527 |
|
|
2025
Q4 | $9.86M | Sell |
198,406
-20,278
| -9% | -$986K | 0.03% | 494 |
|
|
2025
Q3 | $10.5M | Sell |
218,684
-1,620
| -0.7% | -$65.2K | 0.04% | 428 |
|
|
2025
Q2 | $6.94M | Buy |
220,304
+573
| +0.3% | +$18.4K | 0.03% | 529 |
|
|
2025
Q1 | $7.2M | Buy |
219,731
+82,167
| +60% | +$2.91M | 0.03% | 515 |
|
|
2024
Q4 | $4.97M | Buy |
137,564
+20,615
| +18% | +$726K | 0.02% | 650 |
|
|
2024
Q3 | $3.65M | Sell |
116,949
-4,000
| -3% | -$125K | 0.02% | 628 |
|
|
2024
Q2 | $3.24M | Buy |
120,949
+8,967
| +8% | +$260K | 0.02% | 623 |
|
|
2024
Q1 | $3.82M | Sell |
111,982
-1,390
| -1% | -$41.4K | 0.03% | 492 |
|
|
2023
Q4 | $3.28M | Buy |
113,372
+45,895
| +68% | +$1.22M | 0.02% | 552 |
|
|
2023
Q3 | $1.86M | Sell |
67,477
-29,219
| -30% | -$889K | 0.01% | 804 |
|
|
2023
Q2 | $2.91M | Buy |
96,696
+1,621
| +2% | +$56.7K | 0.02% | 710 |
|
|
2023
Q1 | $3.44M | Sell |
95,075
-2,982
| -3% | -$115K | 0.02% | 609 |
|
|
2022
Q4 | $3.5M | Hold |
98,057
| – | – | 0.03% | 602 |
|
|
2022
Q3 | $3.32M | Sell |
98,057
-818
| -0.8% | -$26.6K | 0.03% | 549 |
|
|
2022
Q2 | $2.86M | Sell |
98,875
-381
| -0.4% | -$10.9K | 0.02% | 593 |
|
|
2022
Q1 | $3.21M | Sell |
99,256
-9,090
| -8% | -$279K | 0.02% | 727 |
|
|
2021
Q4 | $3.16M | Hold |
108,346
| – | – | 0.02% | 835 |
|
|
2021
Q3 | $2.89M | Hold |
108,346
| – | – | 0.02% | 890 |
|
|
2021
Q2 | $3.34M | Sell |
108,346
-23,403
| -18% | -$717K | 0.02% | 808 |
|
|
2021
Q1 | $3.45M | Sell |
131,749
-17,938
| -12% | -$502K | 0.02% | 694 |
|
|
2020
Q4 | $3.77M | Buy |
149,687
+14,296
| +11% | +$308K | 0.03% | 581 |
|
|
2020
Q3 | $2.82M | Buy |
135,391
+17,895
| +15% | +$406K | 0.02% | 685 |
|
|
2020
Q2 | $2.79M | Hold |
117,496
| – | – | 0.03% | 613 |
|
|
2020
Q1 | $2.11M | Hold |
117,496
| – | – | 0.02% | 605 |
|
|
2019
Q4 | $2.79M | Sell |
117,496
-16,300
| -12% | -$396K | 0.02% | 952 |
|
|
2019
Q3 | $3.68M | Buy |
133,796
+18,332
| +16% | +$543K | 0.02% | 714 |
|
|
2019
Q2 | $3.82M | Buy |
115,464
+20,800
| +22% | +$713K | 0.03% | 558 |
|
|
2019
Q1 | $3.32M | Buy |
94,664
+9,597
| +11% | +$357K | 0.03% | 454 |
|
|
2018
Q4 | $2.83M | Buy |
85,067
+48,803
| +135% | +$2.1M | 0.02% | 478 |
|
|
2018
Q3 | $1.83M | Buy |
36,264
+2,948
| +9% | +$146K | 0.01% | 677 |
|
|
2018
Q2 | $1.99M | Hold |
33,316
| – | – | 0.01% | 489 |
|
|
2018
Q1 | $1.53M | Sell |
33,316
-15,200
| -31% | -$634K | 0.01% | 537 |
|
|
2017
Q4 | $1.93M | Buy |
48,516
+16,800
| +53% | +$664K | 0.01% | 539 |
|
|
2017
Q3 | $1.27M | Buy |
31,716
+5,916
| +23% | +$256K | 0.01% | 656 |
|
|
2017
Q2 | $1.11M | Sell |
25,800
-9,200
| -26% | -$327K | 0.01% | 688 |
|
|
2017
Q1 | $1.1M | Hold |
35,000
| – | – | 0.01% | 830 |
|
|
2016
Q4 | $884K | Hold |
35,000
| – | – | 0.01% | 903 |
|
|
2016
Q3 | $866K | Buy |
35,000
+11,600
| +50% | +$263K | 0.01% | 871 |
|
|
2016
Q2 | $477K | Hold |
23,400
| – | – | 0.01% | 1050 |
|
|
2016
Q1 | $357K | Hold |
23,400
| – | – | ﹤0.01% | 1091 |
|
|
2015
Q4 | $314K | Sell |
23,400
-14,900
| -39% | -$230K | ﹤0.01% | 1124 |
|
|
2015
Q3 | $537K | Sell |
38,300
-5,400
| -12% | -$100K | ﹤0.01% | 1095 |
|
|
2015
Q2 | $742K | Buy |
+43,700
| New | +$622K | 0.01% | 1132 |
|
Other funds holding SUPN
AC
NAMI
SIMG
Public Sector Pension Investment Board (PSP Investments)'s SUPN Position: Q2 2026 in Review
Public Sector Pension Investment Board (PSP Investments) reduced its Supernus Pharmaceuticals (SUPN) stake by 2.8% in Q2 2026, selling an estimated $279K and leaving 199,351 shares worth $9.27M. The position accounts for 0.02% of the portfolio, ranked #692.
Public Sector Pension Investment Board (PSP Investments) first reported a position in SUPN in Q2 2015 and has held it in 45 quarters since. The position peaked at $10.6M in Q1 2026. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- Public Sector Pension Investment Board (PSP Investments) held 199,351 shares of Supernus Pharmaceuticals worth $9.27M as of Q2 2026.
- Public Sector Pension Investment Board (PSP Investments) sold 5,807 Supernus Pharmaceuticals shares in Q2 2026, an estimated $279K.
- Supernus Pharmaceuticals made up 0.02% of Public Sector Pension Investment Board (PSP Investments)'s portfolio in Q2 2026, its #692 holding.
- Public Sector Pension Investment Board (PSP Investments) first reported a position in Supernus Pharmaceuticals in Q2 2015 and has held it in 45 quarters since.
- Public Sector Pension Investment Board (PSP Investments)'s Supernus Pharmaceuticals position peaked at $10.6M in Q1 2026.
- 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q2 2026, filed 13 Aug 2026.